Target intelligence / Profile preview

High mobility group nucleosome-binding domain-containing protein 1 (HMGN1)

Target
HMGN1
Molecular classification
Chromatin architectural protein, Non-histone chromosomal protein, Epigenetic regulator, Other (not an enzyme, receptor, transporter, ion channel, or transcription factor)
01

Overview

High mobility group nucleosome-binding domain-containing protein 1 (HMGN1) is a small, non-histone chromosomal protein that binds specifically to nucleosomes and influences chromatin structure. It modulates histone post-translational modifications and plays a key role in regulating gene expression, chromatin accessibility, and cellular differentiation. HMGN1 is ubiquitously expressed, most highly during early development and in stem cell populations, and is downregulated as cells differentiate. Loss of HMGN1 impairs responses to DNA damage and cellular stress, leading to increased tumorigenic potential and sensitivity to ionizing or UV radiation. Although HMGN1 strongly affects cell fate and gene regulation, it is not a classical pharmacological target and no drugs directly interact with it

Other names
Non-histone chromosomal protein HMG-14HMGN1HMG14High mobility group nucleosome-binding domain-containing protein 1FLJ27265FLJ31471MGC104230MGC117425High-mobility group nucleosome binding 1Nonhistone chromosomal protein HMG-14
02

Mechanism of action

Null. No direct drugs or small molecules have reported mechanisms of action via targeting HMGN1.

03

Biological functions

Alters chromatin structure via nucleosome bindingModulates epigenetic modifications of nucleosomal histonesRegulates transcriptional activity (optimizes response of transcribable genes)Influences cellular differentiation and embryogenesisParticipates in DNA repair (responses to UV and ionizing radiation)
04

Disease associations

Cancer (loss promotes tumorigenic events through impaired DNA repair and cell cycle checkpoint activation)Cellular response to radiation damageDevelopmental disorders (abnormal differentiation and embryogenesis if dysregulated)Potential role in inflammatory processes (as a chromatin regulator, indirect evidence)

Beyond the preview

Go deeper on High mobility group nucleosome-binding domain-containing protein 1 (HMGN1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on High mobility group nucleosome-binding domain-containing protein 1 (HMGN1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call